Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Engelen

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Handbook of Clinical Neurology|September 25, 2024
Peroxisomal leukodystrophyMarc Engelen
The New England Journal of Medicine|October 5, 2017
Optimizing Treatment for Cerebral Adrenoleukodystrophy in the Era of Gene TherapyMarc Engelen
JAMA Pediatrics|February 10, 2025
Newborn Screening for AdrenoleukodystrophyMarc Engelen, Stephan Kemp
JAMA Neurology|April 19, 2017
Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?Keith Van Haren, Marc Engelen
Seminars in Neurology|March 17, 2012
Peroxisomal leukoencephalopathyBwee Tien Poll-The, Marc Engelen
Handbook of Clinical Neurology|September 25, 2024
AdrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
Handbook of Clinical Neurology|July 16, 2021
Endocrine dysfunction in adrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Paroxysmal non-kinesigenic dyskinesia in antiphospholipid syndromeMarc Engelen, Marina A J Tijssen
Neurology|March 24, 2019
Measuring early lesion growth in boys with cerebral demyelinating adrenoleukodystrophyKeith van Haren, Marc Engelen, Nicole Wolf
JIMD Reports|January 24, 2015
Parkinsonism in phenylketonuria: a consequence of dopamine depletion?Marieke Velema, Erik Boot, Marc Engelen, et al.
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Handbook of Clinical Neurology|September 25, 2024
Peroxisomal leukodystrophyMarc Engelen
The New England Journal of Medicine|October 5, 2017
Optimizing Treatment for Cerebral Adrenoleukodystrophy in the Era of Gene TherapyMarc Engelen
JAMA Pediatrics|February 10, 2025
Newborn Screening for AdrenoleukodystrophyMarc Engelen, Stephan Kemp
JAMA Neurology|April 19, 2017
Decision Making in Adrenoleukodystrophy: When Is a Good Outcome Really a Good Outcome?Keith Van Haren, Marc Engelen
Seminars in Neurology|March 17, 2012
Peroxisomal leukoencephalopathyBwee Tien Poll-The, Marc Engelen
Handbook of Clinical Neurology|September 25, 2024
AdrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
Handbook of Clinical Neurology|July 16, 2021
Endocrine dysfunction in adrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Paroxysmal non-kinesigenic dyskinesia in antiphospholipid syndromeMarc Engelen, Marina A J Tijssen
Neurology|March 24, 2019
Measuring early lesion growth in boys with cerebral demyelinating adrenoleukodystrophyKeith van Haren, Marc Engelen, Nicole Wolf
JIMD Reports|January 24, 2015
Parkinsonism in phenylketonuria: a consequence of dopamine depletion?Marieke Velema, Erik Boot, Marc Engelen, et al.
Pageof 14